Cancer Family
Lung Neoplasm
CI-CAN-00000221Explore in graph →
Non-malignant2,726 active trials51 approved drugs619 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000221Explore in graph →
Clinical trials
11,603 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07490639 | Family-Supported Palliative Care in Advanced Lung Cancer(FSPC-LC) | completed | N/A | 110 | Shanxi Province Cancer HospitalOTHER | 1 | Mar 24, 2026 | clinicaltrials |
| NCT04960059 | NOTION: iN-home Sampling Of cyTokines in ImmunOtherapy patieNts | completed | — | 24 | The Christie NHS Foundation TrustOTHER | 1 | Mar 19, 2026 | clinicaltrials |
| NCT07475637 | Liquid Biopsy Monitoring Of EGFR T790M in Advanced Non-Small Cell Lung Cancer(LBM-T790M) | completed | — | 70 | Faculty of Medicine of TunisOTHER | 1 | Mar 19, 2026 | clinicaltrials |
| NCT02973789 | Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure (LUNAR) | completed | Phase 3 | 291 | NovoCure GmbHINDUSTRY | 18 | Mar 18, 2026 | clinicaltrials |
| NCT06328621 | Lung Cancer Risk Assessment and Etiology | completed | — | 109 | City of Hope Medical CenterOTHER | 1 | Mar 18, 2026 | clinicaltrials |
| NCT02504372 | Study of Pembrolizumab (MK-3475) vs Placebo for Participants With Non-small Cell Lung Cancer After Resection With or Without Standard Adjuvant Therapy (MK-3475-091/KEYNOTE-091)(PEARLS) | completed | Phase 3 | 1,177 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Mar 17, 2026 | clinicaltrials |
| NCT02818920 | Neoadjuvant Pembrolizumab(TOP 1501) | completed | Phase 2 | 35 | Neal Ready MD PhDOTHER | 1 | Mar 17, 2026 | clinicaltrials |
| NCT04298606 | A Vaccine (CIMAvax-EGF) for the Prevention of Lung Cancer Development or Recurrence | completed | Early Phase 1 | 20 | Roswell Park Cancer InstituteOTHER | 1 | Mar 17, 2026 | clinicaltrials |
| NCT01647425 | Alcohol and Tobacco Consumption in Patients With Head and Neck or Lung Cancer(ALTAK) | completed | — | 385 | Centre Oscar LambretOTHER | 1 | Mar 16, 2026 | clinicaltrials |
| NCT01647867 | Study of the Expression of Met Receptor Fragments in Non Small Cell Lung Cancers(MetLung) | completed | N/A | 56 | Centre Oscar LambretOTHER | 1 | Mar 13, 2026 | clinicaltrials |
| NCT02448758 | Cohort of Non-small Cell Lung Cancer With Mutation of the Nord Pas de Calais (CB(NPC)²)(CB(NPC)²) | completed | — | 518 | Centre Oscar LambretOTHER | 1 | Mar 13, 2026 | clinicaltrials |
| NCT02540174 | Alcohol and Tobacco Consumption in Patients With Head and Neck or Lung Cancer : Interest of an Addiction Treatment(ALTAKRA-1405) | completed | N/A | 133 | Centre Oscar LambretOTHER | 1 | Mar 13, 2026 | clinicaltrials |
| NCT06525246 | Study of ONO-7475 in Combination With Osimertinib in EGFR Gene Mutation-positive Non-small Cell Lung Cancer | completed | Phase 1 | 78 | Ono Pharmaceutical Co., Ltd.INDUSTRY | 1 | Mar 13, 2026 | clinicaltrials |
| NCT03313804 | Priming Immunotherapy in Advanced Disease With Radiation | completed | Phase 2 | 76 | John L. Villano, MD, PhDOTHER | 1 | Mar 11, 2026 | clinicaltrials |
| NCT06052449 | Assessing Social Determinants of Health to Increase Cancer Screening | completed | N/A | 101 | Hackensack Meridian HealthOTHER | 1 | Mar 11, 2026 | clinicaltrials |
| NCT02402920 | Pembrolizumab and Concurrent Chemoradiotherapy or Radiation Therapy in Treating Patients With Small Cell Lung Cancer | completed | Phase 1 | 83 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 10, 2026 | clinicaltrials |
| NCT06282991 | A Study to Learn About Lorlatinib in Patients With Non-Small Cell Lung Cancer Which Could Not Be Controlled | completed | — | 73 | PfizerINDUSTRY | 1 | Mar 10, 2026 | clinicaltrials |
| NCT07215026 | Understanding Non-small Cell Lung Cancer Patient Characteristics, Treatment Patterns and Outcomes(UNCOVER) | completed | — | 833 | AstraZenecaINDUSTRY | 1 | Mar 10, 2026 | clinicaltrials |
| NCT02858869 | Pembrolizumab and Stereotactic Radiosurgery for Melanoma or Non-Small Cell Lung Cancer Brain Metastases | completed | Phase 1 | 25 | Emory UniversityOTHER | 1 | Mar 9, 2026 | clinicaltrials |
| NCT04332653 | NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors | completed | Phase 1 / Phase 2 | 215 | NeoImmuneTechINDUSTRY | 1 | Mar 9, 2026 | clinicaltrials |
| NCT04912687 | Implementing Circulating Tumor DNA Analysis at Initial Diagnosis to Improve Management of Advanced NSCLC Patients(CIRCULAR) | completed | N/A | 581 | Institut BergoniéOTHER | 1 | Mar 6, 2026 | clinicaltrials |
| NCT07432308 | Liquid Biopsy Genotyping Using Oncomine Precision Assay GX in Advanced NSCLC(Liquid biopsy) | completed | N/A | 22 | Institute of Oncology LjubljanaOTHER | 1 | Mar 6, 2026 | clinicaltrials |
| NCT01279408 | Observing Patients With Palliative Asymptomatic Centrally Located Advanced Non-small Cell Lung Carcinoma (NSCLC) | completed | — | 46 | University Health Network, TorontoOTHER | 1 | Mar 4, 2026 | clinicaltrials |
| NCT06955468 | Evaluating a Bidirectional Priming Intervention for Goals-of-care Communication in Oncology(Prime GOC) | completed | N/A | 40 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Mar 4, 2026 | clinicaltrials |
| NCT03083041 | A Study of SHR-1210 in Combination With Apatinib in Advanced Non-Small Cell Lung Cancer(NSCLC) | completed | Phase 2 | 210 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Mar 3, 2026 | clinicaltrials |
| NCT04900363 | A Trial of AK112 (PD-1/VEGF Bispecific Antibody) in Patients With NSCLC | completed | Phase 1 / Phase 2 | 108 | AkesoINDUSTRY | 1 | Mar 2, 2026 | clinicaltrials |
| NCT02738398 | FDG PET/CT in Lung Cancer Staging | completed | N/A | 30 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Feb 27, 2026 | clinicaltrials |
| NCT03564197 | 18F-PD-L1 PET/CT in Nivolumab Treated Patients With NSCLC | completed | N/A | 80 | The Netherlands Cancer InstituteOTHER | 1 | Feb 27, 2026 | clinicaltrials |
| NCT04894591 | To Assess the Effectiveness and Safety of Zepzelca in Adult Patients With Extensive Stage Small Cell Lung Cancer (SCLC)(SCLC) | completed | — | 272 | Jazz PharmaceuticalsINDUSTRY | 2 | Feb 27, 2026 | clinicaltrials |
| NCT03724331 | Understanding the Post-Surgical Non-Small Cell Lung Cancer Patient's Symptom Experience | completed | N/A | 235 | University of NebraskaOTHER | 1 | Feb 24, 2026 | clinicaltrials |
| NCT05263947 | Bevacizumab Combined With Double Doses of Icotinib in Advanced NSCLC Patients With EGFR L858R Mutation | completed | Phase 2 | 35 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Feb 24, 2026 | clinicaltrials |
| NCT06361121 | Mid-point Transverse Process to Pleura Block Versus Thoracic Paravertebral Block in Posterolateral Thoracotomy | completed | N/A | 180 | Fayoum University HospitalOTHER | 1 | Feb 23, 2026 | clinicaltrials |
| NCT06000683 | Empowering Patients' Lung Cancer Screening Uptake(Empower-LCS) | completed | N/A | 79 | University of California, IrvineOTHER | 1 | Feb 20, 2026 | clinicaltrials |
| NCT02513563 | AZD1775 Plus Carboplatin-Paclitaxel in Squamous Cell Lung Cancer | completed | Phase 2 | 42 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Feb 19, 2026 | clinicaltrials |
| NCT02523469 | ALT-803 Plus Nivolumab in Patients With Pretreated, Advanced or Metastatic Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 67 | Medical University of South CarolinaOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT03170206 | Study of Palbociclib in Combination With Binimetinib for Patients With Advanced KRAS Mutant Non-Small Cell Lung Cancer | completed | Phase 1 | 34 | Dana-Farber Cancer InstituteOTHER | 1 | Feb 12, 2026 | clinicaltrials |
| NCT05787522 | Clinical Validation of AI-Assisted Radiotherapy Contouring Software for Thoracic Organs at Risk | completed | — | 500 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Feb 12, 2026 | clinicaltrials |
| NCT07050472 | Durvalumab After Concurrent Chemoradiotherapy (cCRT) for Limited-stage Small-cell Lung Cancer (LS-SCLC) | completed | — | 45 | Anhui Shi, MDOTHER | 1 | Feb 12, 2026 | clinicaltrials |
| NCT06575933 | A Study of Calderasib (MK-1084) With Midazolam and Digoxin in Healthy Participants (MK-1084-009) | completed | Phase 1 | 28 | Merck Sharp & Dohme LLCINDUSTRY | 1 | Feb 11, 2026 | clinicaltrials |
| NCT04721106 | Korea Post Marketing Surveillance (PMS) Study of Vizimpro | completed | — | 188 | PfizerINDUSTRY | 1 | Feb 10, 2026 | clinicaltrials |
| NCT02917993 | An Open-Label Phase 1/2 Study of Itacitinib in Combination With Osimertinib in Subjects With Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 59 | Incyte CorporationINDUSTRY | 4 | Feb 9, 2026 | clinicaltrials |
| NCT04384146 | Radiation Therapy to Relieve Symptoms in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 1 | 41 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 9, 2026 | clinicaltrials |
| NCT04407143 | Study of the Immunity of Patients With Lung Cancer and COVID-19 Infection(SOLID) | completed | — | 1,980 | Fundación GECPOTHER | 1 | Feb 9, 2026 | clinicaltrials |
| NCT03879694 | Survivin Long Peptide Vaccine in Treating Patients With Metastatic Neuroendocrine Tumors | completed | Phase 1 | 19 | Roswell Park Cancer InstituteOTHER | 1 | Feb 6, 2026 | clinicaltrials |
| NCT04312308 | A Study for Identification of Predictive Immune Biomarker for Atezolizumab Therapy in NSCLC Patients | completed | — | 100 | Yonsei UniversityOTHER | 1 | Feb 6, 2026 | clinicaltrials |
| NCT04809103 | Intratumoral Cisplatin for Resectable NSCLC | completed | Phase 1 | 6 | University of VermontOTHER | 1 | Feb 6, 2026 | clinicaltrials |
| NCT06018376 | Characteristics of Sexual Dysfunction in Patients With Lung Cancer(LUDICAS) | completed | — | 553 | Fundación GECPOTHER | 5 | Feb 6, 2026 | clinicaltrials |
| NCT07388225 | The Effect of Preoperative Education on Recovery of Thoracic Surgery Patients | completed | N/A | 100 | Başakşehir Çam & Sakura City HospitalOTHER_GOV | 1 | Feb 5, 2026 | clinicaltrials |
Data updated 23 days agoSource updated Mar 24, 2026source: clinicaltrials